FULPHILA

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Lithuania, New Zealand, Poland, Romania.

Active ingredients

The drug FULPHILA contains one active pharmaceutical ingredient (API):

1	Pegfilgrastim UNII 3A58010674 - PEGFILGRASTIM
	Pegfilgrastim is a sustained duration form of filgrastim due to decreased renal clearance. Pegfilgrastim and filgrastim have been shown to have identical modes of action, causing a marked increase in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes and/or lymphocytes.
	Read more about Pegfilgrastim

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FULPHILA Solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L03AA13	Pegfilgrastim	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors
Discover more medicines within L03AA13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	6363X, 9514R
BR	Câmara de Regulação do Mercado de Medicamentos	541521010018407
CA	Health Products and Food Branch	02484153
EE	Ravimiamet	1783076
FI	Lääkealan turvallisuus- ja kehittämiskeskus	107460
FR	Base de données publique des médicaments	60457929
HK	Department of Health Drug Office	66770
IL	מִשְׂרַד הַבְּרִיאוּת	8639
LT	Valstybinė vaistų kontrolės tarnyba	1086597, 1086599
NZ	Medicines and Medical Devices Safety Authority	20523
PL	Rejestru Produktów Leczniczych	100416507
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65788001, W65788002
US	FDA, National Drug Code	67457-833